General Information of This Antigen (ID: TAR0NBDHF)
Antigen Name
Staphylococcus aureus bacteria
Gene Name
S. aureus
Function
Staphylococcus aureus is a major bacterial human pathogen that causes a wide variety of clinical manifestations. Infections are common both in community-acquired as well as hospital-acquired settings and treatment remains challenging to manage due to the emergence of multi-drug resistant strains such as MRSA (Methicillin-Resistant Staphylococcus aureus). S. aureus is found in the environment and is also found in normal human flora, located on the skin and mucous membranes (most often the nasal area) of most healthy individuals. S. aureus does not normally cause infection on healthy skin; however, if it is allowed to enter the bloodstream or internal tissues, these bacteria may cause a variety of potentially serious infections.

    Click to Show/Hide
Each Antibody-drug Conjugate and Its Component Related to This Antigen
Full List of The ADC Related to This Antigen
The Numbers of ADCs, Their Three Components, Payload Targets, and Corresponding Diseases for This Antigens
MSTA3852A
ADC Name Payload Target Linker ADC Info
RG7861
dmDNA31
DNA-directed RNA polymerase II subunit RPB1 (POLR2A)
Mc-Val-Cit-PABC
TAC [1]
dmDNA31
DNA-directed RNA polymerase II subunit RPB1 (POLR2A)
Mc-Val-Cit-PABC
Undisclosed
ADC Name Payload Target Linker ADC Info
ADC based on linker 1 (DAR 2) [2]
Mitomycin C
Human Deoxyribonucleic acid (hDNA)
Undisclosed
ADC based on linker 1 (DAR 5) [2]
Mitomycin C
Human Deoxyribonucleic acid (hDNA)
Undisclosed
ADC based on linker 2 (DAR 2) [2]
Mitomycin C
Human Deoxyribonucleic acid (hDNA)
Undisclosed
37290045 ADC based on linker 2 (DAR 5) [2]
Mitomycin C
Human Deoxyribonucleic acid (hDNA)
Undisclosed
References
Ref 1 Nonclinical toxicology development of a novel antibody antibiotic conjugate for treating invasive Staphylococcus Aureus infections. Toxicol Appl Pharmacol. 2022 Jan 15;435:115811. doi: 10.1016/j.taap.2021.115811. Epub 2021 Dec 9.
Ref 2 Antibody-Drug Conjugates to Treat Bacterial Biofilms via Targeting and Extracellular Drug Release